Mood, food, and cognition: Role of tryptophan and serotonin

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 19, Issue 1, 2016, Pages 55-61

  Strasser, Barbara ^a   Gostner, Johanna M ^a   Fuchs, Dietmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

brain; cognition; food compounds; immunity; mood

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIOXIDANT; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENYLALANINE 4 MONOOXYGENASE; RESVERATROL; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; STILBENE; TRYPTOPHAN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE; VITAMIN;

AGING; BLOOD BRAIN BARRIER; COGNITION; COGNITIVE DEFECT; EXERCISE; FISH; FOOD; FRUIT; HUMAN; IMMUNE SYSTEM; MOOD; NUT; NUTRITION; PERIPHERAL BLOOD MONONUCLEAR CELL; REVIEW; SEROTONIN METABOLISM; TRYPTOPHAN BRAIN LEVEL; VEGETABLE; AFFECT; BRAIN; COGNITION DISORDERS; DEPRESSION; DIET; DRUG EFFECTS; FEEDING BEHAVIOR; METABOLISM;

AFFECT; ANTIOXIDANTS; BRAIN; COGNITION; COGNITION DISORDERS; DEPRESSION; DIET; FOOD HABITS; HUMANS; SEROTONIN; TRYPTOPHAN;

EID: 84951908514     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0000000000000237     Document Type: Review

References (48)

1. Stone TW, Darlington LG. The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br J Pharmacol 2013; 169: 1211-1227.
2. Jones SP, Franco NF, Varney B, et al. Expression of the kynurenine pathway in human peripheral blood mononuclear cells: implications for inflammatory and neurodegenerative disease. PLoS One 2015; 10:e0131389.
3. Dash S, Clarke G, Berk M, Jacka FN. The gut microbiome and diet in psychiatry: focus on depression. Curr Opin Psychiatry 2015; 28:1-6.
4. Leblhuber F, Geisler S, Steiner K, et al. Elevated fecal calprotectin in patients with Alzheimer's dementia indicates leaky gut. J Neural Transm 2015; 122:1319-1322.
5. Munn DH, Mellor AL. Indoleamine 2,3 dioxygenase and metabolic control of immune responses. Trends Immunol 2013; 34:137-143.
6. Lepiller Q, Soulier E, Li Q, et al. Antiviral and immunoregulatory effects of indoleamine-2,3-dioxygenase in hepatitis C virus infection. J Innate Immun 2015; 7:530-544.
7. Capuron L, Geisler S, Kurz K, et al. Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism. Curr Pharm Des 2014; 20:6048-6057.
8. Kurz K, Fiegl M, Holzner B, et al. Fatigue is related with immune-mediated tryptophan degradation in patients with lung cancer. PLoS One 2012; 7:e36956.
9. Gostner JM, Becker K, Kurz K, Fuchs D. Disturbed amino acid metabolism in HIV: association with neuropsychiatric symptoms. Front Psychiatry 2015; 6:97.
10. Haroon E, Raison CL, Miller AH. Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012; 37:137-162.
11. Capuron L,Moranis A, Combe N, et al. Vitamin E status and quality of life in the elderly: influence of inflammatory processes. Br J Nutr 2009; 102:1390-1394.
12. Sperner-Unterweger B, Neurauter G, Klieber M, et al. Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers. Immunobiology 2011; 216:296-301.
13. Capuron L, Schroecksnadel S, Féart C, et al. Chronic low grade immune activation in the elderly is associated with increased tryptophan catabolism and altered phenylalanine turnover: role in neuropsychiatric symptomatology. Biol Psych 2011; 70:175-182.
14. Murr C, Grammer TB, Kleber ME, et al. Low serum tryptophan predicts higher mortality in cardiovascular disease. Eur J Clin Invest 2015; 45:247-254.
15. Seligman F, Nemeroff CB. The interface of depression and cardiovascular disease: therapeutic implications. Ann N Y Acad Sci 2015; 1345:25-35.
16. Gostner JM, Becker K, Ueberall F, Fuchs D. The good and bad of antioxidant foods: an immunological perspective. Food Chem Toxicol 2015; 80:72-79.
17. Gostner JM, Becker K, Fuchs D, Sucher R. Redox regulation of the immune response. Redox Rep 2013; 18:88-94.
18. Alissa EM, Ferns GA. Dietary fruits and vegetables and cardiovascular diseases risk. Crit Rev Food Sci Nutr 2015. [Epub ahead of print]
19. Gostner JM, Schroecknsadel S, Jenny M, et al. Coffee extracts suppress tryptophan breakdown in mitogen-stimulated peripheral blood mononuclear cells. J Am Coll Nutr 2015; 34:212-223.
20. Murr C, Winklhofer-Roob BM, Schroecksnadel K, et al. Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis 2009; 202:543-549.
21. Gostner JM, Marcos-Pérez D, Millán-Calenti JC, et al. Increased neopterin production and tryptophan breakdown in the frail elderly, potential pathophysiologic consequences. Pteridines 2015; 3:120.
22. Gostner JM, Becker K, Croft KD, et al. Black tea consumption increases blood kynurenine concentrations: a randomized controlled trial. Biochim Biophys Acta Clinical 2015; 3:31-35.
23. Jenny M, Klieber M, Zaknun D, et al. In vitro testing for anti-inflammatory properties of compounds employing peripheral blood mononuclear cells freshly isolated from healthy donors. Inflamm Res 2011; 60:127-135.
24. Sperner-Unterweger B, Fuchs D. Schizophrenia and psychoneuroimmunology: an integrative view. Curr Opin Psychiatry 2015; 28:201-206.
25. Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011; 438:397-414.
26. Cunnington C, Van Assche T, Shirodaria C, et al. Systemic and vascular oxidation limits the efficacy of oral tetrahydrobiopterin treatment in patients with coronary artery disease. Circulation 2012; 125:1356-1366.
27. Vogiatzoglou A, Smith AD, Nurk E, et al. Cognitive function in an elderly population: interaction between vitamin B12 status, depression, and apolipoprotein E (4: the Hordaland homocysteine study. Psychosom Med 2013; 75:20-29.
28. Rosenblat JD, Kakar R, McIntyre RS. The cognitive effects of antidepressants in major depressive disorder: a systematic review and meta-analysis of randomized clinical trials. Int J Neuropsychopharmacol 2015. (In press). This meta-analysis extrapolates the evidence of an association between cognition and depression.
29. Silber BY, Schmitt JA. Effects of tryptophan loading on human cognition, mood, and sleep. Neurosci Biobehav Rev 2010; 34:387-407.
30. Dale E, Bang-Andersen B, Sánchez C. Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochem Pharmacol 2015; 95:81-97.
31. Strasser B, Fuchs D. Role of physical activity and diet on mood, behavior, and cognition. Neurol Psychiatry Brain Res 2015. [Epub ahead of print] doi:101016/jnpbr201507002.
32. Gasbarri A, Pompili A. Serotonergic 5-HT7 receptors and cognition. Rev Neurosci 2014; 25:311-323.
33. Gostner JM, Ganzera M, Becker K, et al. Lavender oil suppresses indoleamine 2,3-dioxygenase activity in human PBMC. BMC Complement Altern Med 2014; 14:503.
34. Kasper S, Gastpar M, Müller WE, et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial. Int Clin Psychopharmacol 2010; 25:277-287.
35. Singh M. Mood, food, and obesity. Front Psychol 2014; 5:925.
36. Mangge H, Stelzer I, Reininghaus EZ, et al. Disturbed tryptophan metabolism in cardiovascular disease. Curr Med Chem 2014; 21:1931-1937.
37. Raheja UK, Fuchs D, Giegling I, et al. In psychiatrically healthy individuals, overweight women but not men have lower tryptophan levels. Pteridines 2015; 26:79-84.
38. Shabbir F, Patel A, Mattison C, et al. Effect of diet on serotonergic neurotransmission in depression. Neurochem Int 2013; 62:324-329.
39. Ciardi C, Jenny M, Tschoner A, et al. Food additives sodium sulfite, sodium benzoate and curcumin inhibit leptin release in lipopolysaccharide-treated murine adipocytes in vitro. Br J Nutr 2012; 107:826-833.
40. Mangge H, Summers K, Almer G, et al. Antioxidant food supplements and obesity-related inflammation. Curr Med Chem 2013; 20:2330-2337.
41. Strasser B, Berger K, Fuchs D. Effects of a caloric restriction weight loss diet on tryptophan metabolism and inflammatory biomarkers in overweight adults. Eur J Nutr 2015; 54:101-107.
42. McLean RR, Shardell MD, Alley DE, et al. Criteria for clinically relevant weakness and low lean mass and their longitudinal association with incident mobility impairment and mortality: the foundation for the National Institutes of Health (FNIH) sarcopenia project. J Gerontol A Biol Sci Med Sci 2014; 69:576-583.
43. Volaklis KA, Halle M, Koenig W, et al. Association between muscular strength and inflammatory markers among elderly persons with cardiac disease: results from the KORA-Age study. Clin Res Cardiol 2015. [Epub ahead of print]
44. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care 2012; 15:12-22.
45. Norman K, Stobaüs N, Kulka K, Schulzke J. Effect of inflammation on handgrip strength in the non-critically ill is independent from age, gender and body composition. Eur J Clin Nutr 2014; 68:155-158.
46. Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015; 385:2255-2263.
47. Buchman AS, Boyle PA, Yu L, et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 2012; 78:1323-1329.
48. Meeusen R. Exercise, nutrition and the brain. Sports Med 2014; 44 (Suppl 1):S47-S56.